Star Equity Holdings, Inc.
$10.50+3.86%(+$0.39)
TickerSpark Score
74/100
80
Valuation
35
Profitability
100
Growth
76
Health
80
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a STRR research report →
52-Week Range60% of range
Low $8.26
Current $10.50
High $11.99
Companywww.starequity.com
Star Equity Holdings, Inc. provides healthcare solutions in the United States and internationally. It operates through four segments: Diagnostic Services, Diagnostic Imaging, Construction, and Investments.
- CEO
- Jeffrey E. Eberwein
- IPO
- 2004
- Employees
- 194
- HQ
- Old Greenwich, CT, US
Price Chart
+7.14% · this period
Valuation
- Market Cap
- $38.81M
- P/E
- -4.94
- P/S
- 0.20
- P/B
- 0.64
- EV/EBITDA
- -12.84
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 43.62%
- Op Margin
- -3.14%
- Net Margin
- -4.18%
- ROE
- -13.56%
- ROIC
- -6.77%
Growth & Income
- Revenue
- $172.16M · 222.64%
- Net Income
- $-5,917,000 · 43.31%
- EPS
- $-2.08 · 47.61%
- Op Income
- $-3,688,000
- FCF YoY
- -11.46%
Performance & Tape
- 52W High
- $11.99
- 52W Low
- $8.26
- 50D MA
- $9.69
- 200D MA
- $10.17
- Beta
- 0.41
- Avg Volume
- 7.65K
Get TickerSpark's AI analysis on STRR
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 15, 26 | Eberwein Jeffrey E. | other | 6,504 |
| Mar 31, 26 | Zabkowicz Jacob | buy | 150 |
| Mar 30, 26 | Eberwein Jeffrey E. | sell | 7,722 |
| Mar 25, 26 | Coleman Richard Kenneth Jr. | other | 982 |
| Mar 25, 26 | Coleman Richard Kenneth Jr. | buy | 977 |
| Mar 19, 26 | Coleman Richard Kenneth Jr. | other | 4,537 |
| Mar 25, 26 | Coleman Richard Kenneth Jr. | other | 982 |
| Mar 27, 26 | Fruhbeis Todd Michael | buy | 300 |
| Mar 27, 26 | Fruhbeis Todd Michael | buy | 500 |
| Mar 26, 26 | Fruhbeis Todd Michael | buy | 300 |
Our STRR Coverage
We haven't published any research on STRR yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate STRR Report →Similar Companies
NOTV+4.48%
Inotiv, Inc.
$0.27
BIAF-2.35%
bioAffinity Technologies, Inc.
$1.66
NMTC-0.49%
NeuroOne Medical Technologies Corporation
$4.09
YI-0.87%
111, Inc.
$5.73
ECOR+3.81%
electroCore, Inc.
$6.13
DYAI+2.30%
Dyadic International, Inc.
$0.74
LIMN-1.16%
Liminatus Pharma, Inc. Class A Common Stock
$0.19
BDSX+3.08%
Biodesix, Inc.
$14.37